Correlation Between Verrica Pharmaceuticals and Viridian Therapeutics
Can any of the company-specific risk be diversified away by investing in both Verrica Pharmaceuticals and Viridian Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verrica Pharmaceuticals and Viridian Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verrica Pharmaceuticals and Viridian Therapeutics, you can compare the effects of market volatilities on Verrica Pharmaceuticals and Viridian Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verrica Pharmaceuticals with a short position of Viridian Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verrica Pharmaceuticals and Viridian Therapeutics.
Diversification Opportunities for Verrica Pharmaceuticals and Viridian Therapeutics
-0.6 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Verrica and Viridian is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Verrica Pharmaceuticals and Viridian Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viridian Therapeutics and Verrica Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verrica Pharmaceuticals are associated (or correlated) with Viridian Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viridian Therapeutics has no effect on the direction of Verrica Pharmaceuticals i.e., Verrica Pharmaceuticals and Viridian Therapeutics go up and down completely randomly.
Pair Corralation between Verrica Pharmaceuticals and Viridian Therapeutics
Given the investment horizon of 90 days Verrica Pharmaceuticals is expected to under-perform the Viridian Therapeutics. In addition to that, Verrica Pharmaceuticals is 3.22 times more volatile than Viridian Therapeutics. It trades about -0.02 of its total potential returns per unit of risk. Viridian Therapeutics is currently generating about 0.0 per unit of volatility. If you would invest 2,217 in Viridian Therapeutics on August 31, 2024 and sell it today you would lose (30.00) from holding Viridian Therapeutics or give up 1.35% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Verrica Pharmaceuticals vs. Viridian Therapeutics
Performance |
| Timeline |
| Verrica Pharmaceuticals |
| Viridian Therapeutics |
Verrica Pharmaceuticals and Viridian Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Verrica Pharmaceuticals and Viridian Therapeutics
The main advantage of trading using opposite Verrica Pharmaceuticals and Viridian Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verrica Pharmaceuticals position performs unexpectedly, Viridian Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viridian Therapeutics will offset losses from the drop in Viridian Therapeutics' long position.| Verrica Pharmaceuticals vs. Cue Biopharma | Verrica Pharmaceuticals vs. Eliem Therapeutics | Verrica Pharmaceuticals vs. Inhibrx | Verrica Pharmaceuticals vs. Molecular Partners AG |
| Viridian Therapeutics vs. Nuvalent | Viridian Therapeutics vs. Arcellx | Viridian Therapeutics vs. Vaxcyte | Viridian Therapeutics vs. Crinetics Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |